Navigation Links
Revealing Relationships Between the Clinical and Immunological Response in Vaccination Trials, New Life Science Webinar Hosted by Xtalks
Date:9/16/2013

Toronto, Canada (PRWEB) September 16, 2013

Immune monitoring of patients enrolled in vaccination trials has become crucial to help guide the development of immunotherapies and reveal potential relationships between the clinical and immunological response. The lack of protective signatures is partly explained by the realization that monoparametric, or “one-track” evaluations fail to capture the heterogeneity of the immune response. Therefore, multiparametric, or “multi-track” flow cytometry has become the tool of choice given its ability to simultaneously analyze the relative distribution of cellular phenotypes and functions in complex mixtures of cells such as in peripheral blood and tissues.

In a new webinar hosted by XTalks, speakers will describe the tools used to comprehensively monitor antigen-specific T cells and evaluate the immunostimulatory and suppressive compartments. The analytical tools evaluate how these cellular subsets shift in phenotype and function during disease and following vaccination with the objective of discovering correlates and predictive biomarkers of immune protection.

For more information about this event or to register, visit: http://xtalks.com/vaccination-trials.ashx

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx.

Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/9/prweb11123233.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Innovative MetaMorph® NX Software Shatters Barriers Between Researchers and Image Analysis Goals with Exclusive Visual Workflow
2. EveryDayMatters.com Aims to Raise Awareness and Coordinate Care Between Mental and Physical Health
3. Researchers Find Potential Link Between Drinking Alcohol And Breast Cancer
4. Collaboration between Sanofi and Joslin Diabetes Center to focus on new drugs for diabetes
5. Triboelectric generator produces electricity by harnessing friction between surfaces
6. Blue Brain Project accurately predicts connections between neurons
7. Mangrove Partners Agrees to Support Amended Transaction Between Nabi Biopharmaceuticals and Biota Holdings
8. Pulmonary fibrosis: Between a ROCK and a hard place
9. Partnership between EBSCO Publishing and BioOne Online Journals Adds Scholarly Biological, Ecological and Environment Sciences Articles to EBSCO Discovery Service™
10. Probiotic Action Shares New Insight on the Link Between Sugar, Probiotics, and Acne
11. Probiotic Action Explains the New Link Between Probiotics, Bacteria and Eczema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... 29, 2016 , ... Summit for Stem Cell has received a $250,000 grant ... stem cell therapy for the treatment of Parkinson’s disease. The Summit research project is ... Scripps Research Institute in San Diego, CA. , The aim of of ...
(Date:4/28/2016)... Hill, Conn. (PRWEB) , ... April 28, 2016 ... ... of financing and ongoing support for Connecticut's innovative, growing companies, today announced the ... digital health and financial technology (fintech) companies. , “VentureClash looks to ...
(Date:4/27/2016)... ... 2016 , ... Shimadzu Scientific Instruments (SSI) will be showcasing ... Conference and Expo. Shimadzu’s high-performance instruments enable laboratories to test cannabis products for ... stop by booth 1021 to learn how Shimadzu’s instruments can help improve QA/QC ...
(Date:4/27/2016)... ... 27, 2016 , ... The Board of Directors of Biohaven ... Tilton as Chief Commercial Officer.  Mr. Tilton joined Biohaven from Alexion Pharmaceuticals, Inc. ... responsible for the commercialization of multiple orphan drug indications. Mr. Tilton has ...
Breaking Biology Technology:
(Date:3/14/2016)... Allemagne, March 14, 2016 ... - --> - Renvoi : image disponible ... --> --> DERMALOG, ... fournit de nouveaux lecteurs d,empreintes digitales pour l,enregistrement ... DERMALOG sera utilisé pour produire des cartes d,identité ...
(Date:3/10/2016)... --  Unisys Corporation (NYSE: UIS ) today announced ... testing its biometric identity solution at the Otay Mesa border ... identify certain non-U.S. citizens leaving the country. ... determine the efficiency and accuracy of using biometric technologies in ... until May 2016. --> the United States ...
(Date:3/8/2016)... 2016   Valencell , the leading innovator ... has secured $11M in Series D financing. The ... venture fund being launched by UAE-based financial services ... investors TDF Ventures and WSJ Joshua Fund. Valencell ... triple-digit growth and accelerate its pioneering innovation in ...
Breaking Biology News(10 mins):